(Q34070852)

30 July 2017

title

Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children (English)

1 reference

30 July 2017

1 reference

6

J André Knottnerus

1 reference

Antoinette D I van Asselt

30 July 2017

4

object named as

Antoinette D I van Asselt

1 reference

30 July 2017

G Feljandro P Ramos

1

1 reference

30 July 2017

Sandra Kuiper

2

1 reference

30 July 2017

Edward Dompeling

3

1 reference

30 July 2017

Wim J C de Grauw

5

1 reference

30 July 2017

Onno C P van Schayck

7

1 reference

30 July 2017

Tjard R J Schermer

8

1 reference

30 July 2017

Johan L Severens

9

1 reference

30 July 2017

publication date

9 November 2011

1 reference

BMC Medical Research Methodology

30 July 2017

published in

1 reference

30 July 2017

volume

11

1 reference

30 July 2017

page(s)

150

1 reference

Creative Commons Attribution 2.0 Generic

30 July 2017

copyright license

start time

9 November 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Mono and multifaceted inhalant and/or food allergen reduction interventions for preventing asthma in children at high risk of developing asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

Economic burden of asthma: a systematic review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

Vitalum study design: RCT evaluating the efficacy of tailored print communication and telephone motivational interviewing on multiple health behaviors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

Methodological issues in evaluating cost effectiveness of adjuvant aromatase inhibitors in early breast cancer: a need for improved modelling to aid decision making

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

The effects of involving a nurse practitioner in primary care for adult patients with urinary incontinence: the PromoCon study (Promoting Continence).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

Modelling methods for pharmacoeconomics and health technology assessment: an overview and guide

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

Is there any role for allergen avoidance in the primary prevention of childhood asthma?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

Cost effectiveness of palivizumab for respiratory syncytial virus prophylaxis in high-risk children: a UK analysis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

Health economic evaluations: how to find them

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

Whither trial-based economic evaluation for health care decision making?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

Modelling in the economic evaluation of health care: selecting the appropriate approach

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

Primary prevention of asthma and atopy during childhood by allergen avoidance in infancy: a randomised controlled study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

Measuring costs and consequences in economic evaluation in asthma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

Elicitation of quantitative data from a heterogeneous expert panel: formal process and application in animal health

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

Searching literature databases for health care economic evaluations: how systematic can we afford to be?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

Modelling in health economic evaluation. What is its place? What is its value?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

The use of consensus methods and expert panels in pharmacoeconomic studies. Practical applications and methodological shortcomings

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

Modelling in economic evaluation: an unavoidable fact of life

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226537

An international observational prospective study to determine the cost of asthma exacerbations (COAX).

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

Primary prevention of asthma and allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

The Prevention and Incidence of Asthma and Mite Allergy (PIAMA) birth cohort study: Design and first results

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

The PREVASC study: the clinical effect of a multifaceted educational intervention to prevent childhood asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

The primary prevention of asthma in children study: design of a multifaceted prevention program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

Interactive effect of family history and environmental factors on respiratory tract-related morbidity in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

Selecting a decision model for economic evaluation: a case study and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

A taxonomy of model structures for economic evaluation of health technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

Expert judgement in pharmacoeconomic studies. Guidance and future use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

Testing the validity of cost-effectiveness models

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

Validation of health economic models: the example of EVITA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

A decision aid for COPD patients considering inhaled steroid therapy: development and before and after pilot testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

The economic evaluation of prevention--let's talk about values and the case of discounting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

Structural changes of the airway wall impair respiratory function, even in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

Performance of the ISAAC questionnaire to establish the prevalence of asthma in adolescents: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

Empirically evaluating decision-analytic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

Association between first-degree familial predisposition of asthma and atopy (total IgE) in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

Primer on Medical Decision Analysis: Part 2—Building a Tree

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-11-150

Prevention of asthma in genetically predisposed children in primary care--from clinical efficacy to a feasible intervention programme

21 January 2018

1 reference

12 December 2020

Comparing model structures in cost-effectiveness analysis

1 reference

12 December 2020

Analytic choices in economic models of treatments for rheumatoid arthritis: What makes a difference?

1 reference

12 December 2020

Prevention of asthma during the first 5 years of life: A randomized controlled trial

1 reference

12 December 2020

Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease

1 reference

12 December 2020

Cost-utility of a disease management program for patients with asthma

1 reference

12 December 2020

Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France

1 reference

12 December 2020

Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2288-11-150

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference